John N. Kapoor
Fondatore presso EJ Financial Enterprises, Inc.
Profilo
John N.
Kapoor is the founder of Option Care, Inc. (Illinois) (founded in 1979) where he held the title of Chairman & President in 1996.
He is also the founder of EJ Financial Enterprises, Inc. (founded in 1990) where he currently holds the title of Chairman & President.
Additionally, he is the founder of Kapoor-Pharma Investments LP (founded in 2000) where he currently holds the title of Managing Partner.
He was also the founder of INSYS Therapeutics, Inc. (founded in 1990) where he held the title of Director in 2017.
Dr. Kapoor's current job(s) include being a Director at Insys Pharma, Inc. since 2002 and a Trustee at Dr. Kapoor Trust Ltd.His former job(s) include being the Chief Executive Officer & Director at Unimed Pharmaceuticals LLC from 1991 to 1993, Chairman, President & Chief Executive Officer at Lyphomed, Inc. from 1982 to 1990, Chairman at Akorn, Inc. from 1990 to 2017, Chairman at NeoPharm, Inc. from 1990 to 2011, Non-Executive Chairman at Shionogi Pharma, Inc. in 1992, Director at Bone Care International, Inc., Director at Introgen Therapeutics, Inc. from 1993 to 2007, Director at Duska Scientific Co. from 2001 to 2006, and Director at Cordex Pharma, Inc. from 2004 to 2006.
Dr. Kapoor obtained a doctorate degree from the State University of New York at Buffalo in 1970 and an undergraduate degree from the University of Mumbai.
Posizioni attive di John N. Kapoor
| Società | Posizione | Inizio |
|---|---|---|
EJ Financial Enterprises, Inc.
 EJ Financial Enterprises, Inc. SteelNon-Energy Minerals EJ Financial Enterprises, Inc. provides financial services. It offers advisory, mutual funds and startup investments services to the healthcare sector. The company was founded in 1990 and is headquartered in Lake Forest, IL. | Fondatore | 19/08/2010 |
| Kapoor-Pharma Investments LP | Fondatore | 31/03/2011 |
| Insys Pharma, Inc. | Direttore/Membro del Consiglio | 01/01/2002 |
| John N. Kapoor Trust Ltd. | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di John N. Kapoor
| Società | Posizione | Fine |
|---|---|---|
| AKORN, INC. | Presidente | 30/10/2017 |
| INSYS THERAPEUTICS, INC. | Amministratore Delegato | 09/01/2017 |
NeoPharm, Inc.
 NeoPharm, Inc. BiotechnologyHealth Technology NeoPharm, Inc. engages in the research, development, and commercialization of drugs for the treatment of various cancers and other diseases. The company has built its drug development program around two proprietary technology platforms, a tumor-targeting toxin platform which includes development for a new indication of Pulmonary Fibrosis, and a novel NeoLipid liposomal drug delivery system. It has advanced five drug product candidates in various stages of clinical and pre clinical development for the treatment of cancer and one drug product candidate in pre-clinical development for treatment of interstitial pulmonary fibrosis and asthma. NeoPharm was founded in May 15, 1900and is headquartered in Lake Bluff, IL. | Presidente | 02/05/2011 |
| INTROGEN THERPUT | Direttore/Membro del Consiglio | 05/06/2007 |
Shionogi Pharma, Inc.
 Shionogi Pharma, Inc. Pharmaceuticals: MajorHealth Technology Shionogi Pharma, Inc. manufactures pharmaceuticals. The company is headquartered in Alpharetta, GA. | Presidente | 01/12/2006 |
Formazione di John N. Kapoor
| State University of New York at Buffalo | Doctorate Degree |
| University of Mumbai | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 15 |
|---|---|
Akorn, Inc.
 Akorn, Inc. Pharmaceuticals: MajorHealth Technology Akorn, Inc. engages in the development, manufacture, and marketing of generic and prescription pharmaceuticals, and animal and consumer health products. It manufactures and markets branded and generic products including ophthalmic, injectable, oral liquids, topical, inhalants, and nasal sprays. The company was founded in 1971 and is headquartered in Lake Forest, IL. | Health Technology |
Unimed Pharmaceuticals LLC
 Unimed Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Unimed Pharmaceuticals, Inc. manufactured pharmaceutical products. It provided multiple indications in the therapeutic areas of cardiology, men's health, HIV and other infectious diseases. The company was founded in 1948 and was headquartered in Marietta, GA. | Health Technology |
NeoPharm, Inc.
NeoPharm, Inc. BiotechnologyHealth Technology NeoPharm, Inc. engages in the research, development, and commercialization of drugs for the treatment of various cancers and other diseases. The company has built its drug development program around two proprietary technology platforms, a tumor-targeting toxin platform which includes development for a new indication of Pulmonary Fibrosis, and a novel NeoLipid liposomal drug delivery system. It has advanced five drug product candidates in various stages of clinical and pre clinical development for the treatment of cancer and one drug product candidate in pre-clinical development for treatment of interstitial pulmonary fibrosis and asthma. NeoPharm was founded in May 15, 1900and is headquartered in Lake Bluff, IL. | Health Technology |
Option Care, Inc. (Illinois)
 Option Care, Inc. (Illinois) Medical/Nursing ServicesHealth Services Option Care, Inc. provides specialty pharmacy and home infusion services. It services include home infusion, specialty pharmacy, ambulatory treatment, respiratory therapy, and home medical equipment. The company was founded in 1979 and is headquartered in Buffalo Grove, IL. | Health Services |
Bone Care International, Inc.
 Bone Care International, Inc. Pharmaceuticals: OtherHealth Technology Bone Care International, Inc. developed innovative therapeutic products. Its products included Hectorol Injections and Capsules. The company was located in Middleton, WI. | Health Technology |
Introgen Therapeutics, Inc.
 Introgen Therapeutics, Inc. Medical SpecialtiesHealth Technology Introgen Therapeutics, Inc. is a biopharmaceutical company focuses on the discovery, development and commercialization of targeted molecular therapies for the treatment of cancer and other diseases. The company develops molecular therapeutics, immunotherapies, vaccines and nano-particle tumor suppressor therapies to treat a wide range of cancers using tumor suppressors, cytokines and genes. The company maintains integrated research, development, manufacturing, clinical and regulatory departments and operates multiple manufacturing facilities including a commercial scale cGMP manufacturing facility. It was founded in June 1993 and is headquartered in Austin, TX. | Health Technology |
| John N. Kapoor Trust Ltd. | |
Shionogi Pharma, Inc.
Shionogi Pharma, Inc. Pharmaceuticals: MajorHealth Technology Shionogi Pharma, Inc. manufactures pharmaceuticals. The company is headquartered in Alpharetta, GA. | Health Technology |
EJ Financial Enterprises, Inc.
EJ Financial Enterprises, Inc. SteelNon-Energy Minerals EJ Financial Enterprises, Inc. provides financial services. It offers advisory, mutual funds and startup investments services to the healthcare sector. The company was founded in 1990 and is headquartered in Lake Forest, IL. | Non-Energy Minerals |
| Kapoor-Pharma Investments LP | |
Duska Scientific Co.
 Duska Scientific Co. Pharmaceuticals: MajorHealth Technology Part of Cordex Pharma, Inc., Duska Scientific Co. is a company that manufactures biopharmaceutical products. The company is based in Haverford, PA. | Health Technology |
Cordex Pharma, Inc.
 Cordex Pharma, Inc. Medical SpecialtiesHealth Technology Cordex Pharma, Inc. is a specialty pharmaceutical company that develops new cardiovascular medicines based upon the emerging pharmacology of adenosine 5'-triphosphate (ATP) and nitric oxide (NO). These two molecules play critical roles in cellular metabolism and signal transduction, the manipulation of which constitute novel therapeutic modalities for the treatment of major cardiovascular disorders. Cordex Pharma was founded on February 9, 1996 and is headquartered in Philadelphia, PA. | Health Technology |
| Lyphomed, Inc. | Health Technology |
INSYS Therapeutics, Inc.
 INSYS Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology INSYS Therapeutics, Inc. operates as a pharmaceutical company, which develops and commercializes supportive care products. It focuses on utilizing commercial pharmaceutical products that include Subsys, a proprietary sublingual fentanyl spray for BTCP in opioid-tolerant adult patients; and Syndros, a proprietary orally administered liquid formulation of dronabinol for the treatment of CINV and anorexia associated with weight loss in patients with AIDS. The company was founded by John N. Kapoor on June 15, 1990 and is headquartered in Chandler, AZ. | Health Technology |
| Insys Pharma, Inc. |
- Borsa valori
- Insiders
- John N. Kapoor
